title: Development of chorea with lupus anticoagulant after interferon therapy.
authors.affiliation: Department of Neurology, Hôpital Jean-Bernard, CHU la Milétrie, Poitiers, France.
authors.forename: J P
authors.initials: JP
authors.lastname: Neau
authors.forename: F
authors.initials: F
authors.lastname: Guilhot
authors.forename: C
authors.initials: C
authors.lastname: Boinot
authors.forename: P
authors.initials: P
authors.lastname: Dumas
authors.forename: A M
authors.initials: AM
authors.lastname: Tantot
authors.forename: R
authors.initials: R
authors.lastname: Gil
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D002648:Child; D002819:Chorea / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D016682:Lupus Coagulation Inhibitor / Q000032:analysis; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000209:etiology*; D011994:Recombinant Proteins
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D016682:Lupus Coagulation Inhibitor; D011994:Recombinant Proteins